Archives for March 12, 2013

← 2013

WuXi PharmaTech Looks Ahead to Profitable 2013

By Zachary Brennan

CRO WuXi PharmaTech has announced 22% net revenue growth in 2012 as its China-based lab services grew significantly. That trend is expected to continue with double-digit growth in 2013.